WILLIS C. LEE - 12 Jan 2023 Form 4/A - Amendment Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
COO, Director
Signature
Willis C. Lee
Issuer symbol
EMMA
Transactions as of
12 Jan 2023
Transactions value $
$2,250,000
Form type
4/A - Amendment
Filing time
19 Jan 2023, 16:54:15 UTC
Date Of Original Report
17 Jan 2023
Previous filing
02 Jun 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EMMA Options Award $2.25M +500K $4.50 500K 12 Jan 2023 Common Stock 500K $4.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary.